Overview
To learn more about how the delivery of medical information affects therapy choices for participants with advanced forms of cancer.
Description
Primary Objectives • To examine how provision of medical information (risks, benefits, time toxicity, prognosis, oncologists' recommendation, and costs) affects preference for palliative systemic therapy in participants with advanced cancer.
Secondary Objective
• To examine how different options of medical information (risks/benefits, time toxicity, prognosis, oncologists' recommendation, and costs) affect preference for palliative systemic therapy in participants with advanced cancer.
Exploratory Objective
- To examine how the order of presentation of medical information affects preference for palliative systemic therapy in participants with advanced cancer.
- To examine the association between intrinsic participants characteristics (such as participants demographics, symptoms, anxiety, depression, illness understanding, acceptance, coping strategies, religious coping, hope, decision making style, trust in oncologist, financial distress) and preference for palliative systemic therapy in participants with advanced cancer.
Eligibility
Inclusion Criteria:
Diagnosis of advanced solid tumor (i.e. metastatic, relapsed, and/or incurable disease) or aggressive lymphoma.
- Age 18 or greater
- Seen at MD Anderson Cancer Center Thoracic and Lymphoma Oncology Clinics for a follow-up visit
- Been treated with at least 2 lines of palliative systemic cancer therapies
Exclusion Criteria:
- Diagnosis of cognitive impairment or dementia requiring a surrogate decision maker
- Non-English speaking